Notice of Correction to Eligibility Information in RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
Notice Number:
NOT-HL-22-008

Key Dates

Release Date:

February 4, 2022

Related Announcements

NOT-HL-22-013 - Notice of Correction to Eligibility and Application Types in RFA-HL-23-006, " Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"

RFA-HL-23-006 - Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)

NOT-HL-22-009 - Notice of Correction to Specific Areas of Research Interest of Participating Institutes and Centers In

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On January 18, 2022, the National Heart, Lung and Blood Institute (NHLBI) issued Funding Opportunity Announcement (FOA) RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)". The purpose of this Notice is to inform the applicant community that Multiple PD/PIs are permitted when submitting applications to this FOA.

The following section of RFA-HL-23-006 has been modified:

Currently Reads:

Part 2. Full Text of Announcement

Section III. Eligibility Information

1. Eligible Applicants

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.

Multiple PD/PIs are not allowed.
 

The Institutional PD/PI should be an established clinician-investigator in a relevant scientific area and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI must have a regular, full-time appointment (i.e., not adjunct, part-time, or emeritus) at the applicant institution. This person should hold a health professional degree (e.g., MD, DVM, DDS or equivalents), have an appointment in a clinical department related to at least one of the residency programs proposed for participation, have clearly demonstrated education/mentoring experience and have a strong recent history of NIH funding. Exceptional individuals without a clinical doctorate and with demonstrated leadership and mentoring experience in clinical departments may also serve as PD/PI. If the sponsoring institution is a hospital affiliated with a medical or dental school, the PD/PI must have an appointment in both the medical/dental school and at the sponsoring institution.

The Institutional PD/PI will design and provide oversight for the entire program. The PD/PI is expected to monitor and assess the program annually, and submit all documents and reports as required.

Modified to Read:

Part 2. Full Text of Announcement

Section III. Eligibility Information

1. Eligible Applicants

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and women are always encouraged to apply for NIH support. See, Reminder: Notice of NIH's Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities, NOT-OD-22-019.

The Institutional PD/PI should be an established clinician-investigator in a relevant scientific area and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI must have a regular, full-time appointment (i.e., not adjunct, part-time, or emeritus) at the applicant institution. This person should hold a health professional degree (e.g., MD, DVM, DDS or equivalents), have an appointment in a clinical department related to at least one of the residency programs proposed for participation, have clearly demonstrated education/mentoring experience and have a strong recent history of NIH funding. Exceptional individuals without a clinical doctorate and with demonstrated leadership and mentoring experience in clinical departments may also serve as PD/PI. If the sponsoring institution is a hospital affiliated with a medical or dental school, the PD/PI must have an appointment in both the medical/dental school and at the sponsoring institution.

The Institutional PD/PI will design and provide oversight for the entire program. The PD/PI is expected to monitor and assess the program annually, and submit all documents and reports as required.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

David Schopfer, M.D.
National Heart Lung and Blood Institute (NHLBI)
Telephone: 301-402-3833
Email: david.schopfer@nih.gov